Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Ballantyne

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Circulation|July 1, 1995
Cardiac allograft survival in mice deficient in intercellular adhesion molecule-1K O Schowengerdt, J Y Zhu, S M Stepkowski, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 21, 2000
Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout miceS A Briaud, Z M Ding, L H Michael, et al.
Atherosclerosis|March 21, 2001
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatinS Turban, F Fuentes, L Ferlic, et al.
Circulation|September 6, 2001
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyA R Sharrett, C M Ballantyne, S A Coady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994
Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated formA G Kumar, X Y Dai, C A Kozak, et al.
International Journal of Clinical Practice|August 18, 2004
Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemiaC M Ballantyne, L J Lipka, P T Sager, et al.
Current Opinion in Lipidology|December 31, 1997
Effects of lipid lowering therapy on progression of coronary and carotid artery diseaseC M Ballantyne, J A Herd, J K Dunn, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2007
Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities StudyA Vigo, B B Duncan, M I Schmidt, et al.
Circulation|April 1, 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemiaA Hackman, Y Abe, W Insull, et al.
Controlled Clinical Trials|December 1, 1996
The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemiaM S West, J A Herd, C M Ballantyne, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Circulation|July 1, 1995
Cardiac allograft survival in mice deficient in intercellular adhesion molecule-1K O Schowengerdt, J Y Zhu, S M Stepkowski, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 21, 2000
Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout miceS A Briaud, Z M Ding, L H Michael, et al.
Atherosclerosis|March 21, 2001
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatinS Turban, F Fuentes, L Ferlic, et al.
Circulation|September 6, 2001
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyA R Sharrett, C M Ballantyne, S A Coady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994
Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated formA G Kumar, X Y Dai, C A Kozak, et al.
International Journal of Clinical Practice|August 18, 2004
Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemiaC M Ballantyne, L J Lipka, P T Sager, et al.
Current Opinion in Lipidology|December 31, 1997
Effects of lipid lowering therapy on progression of coronary and carotid artery diseaseC M Ballantyne, J A Herd, J K Dunn, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2007
Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities StudyA Vigo, B B Duncan, M I Schmidt, et al.
Circulation|April 1, 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemiaA Hackman, Y Abe, W Insull, et al.
Controlled Clinical Trials|December 1, 1996
The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemiaM S West, J A Herd, C M Ballantyne, et al.
Pageof 12